Mission Hospital has an award-winning staff that is leading the way in medical ingenuity. Our accomplishments have led to such awards as the Outstanding Achievement Award for the Commission on Cancer in 2008 – causing us to be one of 66 hospitals in the entire nation to be honored. Combining care for the mind, body and spirit, we take a unique approach to every individual patient.
Go paperless and manage your account online.
Use our online physician search to find the right doctor for you.
See the newborns of your loved ones here.
We provide a number of classes & events, click here to see them.
31872 Coast Highway
Laguna Beach, CA 92651
27700 Medical Center Road
Mission Viejo, CA 92691
Find out more about how we're helping the community.
Learn about the many ways to help us at Mission Hospital.
Give the gift of time!Click here to learn more.
All breast cancers are now tested for the estrogen and progesterone receptors. These receptors are molecules in the cancer cells that can accept hormones and influence the growth of the cancer. Breast cancers that are hormone receptor positive have two important characteristics. First, they tend to be less aggressive than the same type of breast cancer that is hormone receptor negative. They also are influenced by various hormone manipulations that generally decrease the level of estrogen in the body. The percent of patients that have positive estrogen receptor increases with age. The response to various hormone manipulations is proportional to the level of estrogen receptor meaning that patients with high levels of estrogen receptor are more responsive to various hormone manipulations.
Anti-hormonal drugs that have been developed during the past 20 or 30 years include:
Patients with invasive breast cancer who are shown to be estrogen receptor positive may benefit by additional antiestrogen therapy. In premenopausal patients, the usual recommendation for therapy is five years of tamoxifen, but there are a number of research studies looking at more aggressive anti-estrogen manipulation including LHRH agonist, followed by either tamoxifen or an aromatase inhibitor. The results of these studies are pending, but should be available in the next year or two. In postmenopausal patients, it has now been shown that the initial approach that yields the most benefit is to start with an aromatase inhibitor. This clearly decreases the chance of recurrence and increases the long-term disease free survival. Various research studies are now looking into whether more than five years of an aromatase inhibitor is beneficial and early indications are that 10 years of anti-estrogen therapy in some situations may be more effective than five years.
In situations in which breast cancer has recurred in distant sites and the tumor is estrogen receptor positive, hormone manipulation may control the tumor for many years. A sequence of hormone therapies can often keep the disease under control for many years before chemotherapy is needed. Hormone therapy is much easier and often has longer response rates than chemotherapy. Various hormone manipulations include tamoxifen in both premenopausal and postmenopausal women. In postmenopausal women, the aromatase inhibitors and Faslodex also play an important role in tumor control. If patients are responsive to these anti-hormone therapies, other hormone approaches might include Faslodex or Megace or high dose estrogen.
For more information about our Women's Center, please call us:
Health Information Line
Mission Hospital in Mission Viejo
Mission Hospital Laguna Beach
Find a Physician |
Health Resource Center |
Physicians Only |
For Employees |